KSP, McLaren's Specialty Pharmacy, Earns Fourth Consecutive URAC Performance Leadership Award
Event summary
- KSP, McLaren's Specialty Pharmacy, received the 2025 URAC Pioneer award in Leaders in Performance Measurement for the fourth consecutive year.
- The recognition is based on data collected from January 1 to December 31, 2024, and evaluated by URAC's Quality, Research, and Measurement Team.
- KSP coordinates high-cost biologic treatments and specialty oncology medications across Michigan, Indiana, Ohio, and Florida.
- Recent updates include a new medication maintenance app enabling real-time care management through an enhanced patient portal.
The big picture
KSP's repeated recognition by URAC underscores the growing emphasis on performance measurement in specialty pharmacy services. As healthcare systems increasingly prioritize quality and efficiency, KSP's commitment to streamlined processes and patient-centric care positions it as a key player in the evolving landscape of oncology and chronic disease management. McLaren Health Care's integration of KSP across multiple states further solidifies its role in delivering high-cost biologic treatments and specialty medications.
What we're watching
- Sustainability of Performance
- Whether KSP can maintain its leadership position in performance measurement amid evolving healthcare standards.
- Technological Integration
- The pace at which KSP's new medication maintenance app will enhance patient outcomes and operational efficiency.
- Market Expansion
- How KSP's multi-state reach will impact its ability to serve more patients with complex, chronic diseases.